Argentina
Colombia
Malaysia
Mexico
Other LatAm Countries
English
-
-
Dengue in the Midst of COVID-19 Pandemic
ADVA14 minutes -
What is the diagnosis? - Challenging Pediatric ID Cases in Dengue Endemic Regions
WSPID59 minutes -
Emerging Issues in Dengue Control
Takeda -
Latest Research on Dengue Science
Takeda -
Experience of a tertiary hospital in Singapore managing a dual outbreak of COVID and dengue
Takeda2 minutes -
Case report: Acute vision loss in a young returning traveler with dengue fever
Takeda2 minutes -
Covid-19 and dengue: Double punches for dengue-endemic countries in Asia
Takeda2 minutes -
First autochthonous dengue outbreak in Italy, August 2020
Takeda2 minutes -
Insecticide resistance in dengue vectors from hotspots in Selangor, Malaysia
Takeda2 minutes -
Dengue is the most common non-malarial febrile illness in Southern Asia and Southeastern Asia
Takeda2 minutes -
When fever is not malaria in Latin America
Takeda2 minutes -
Similarities and differences between 'cytokine storms’ in acute dengue and COVID-19
Takeda2 minutes -
Dengue: Not Just 1 Virus, Not Just 1 Infection
Medscape15 minutes -
Surveillance and Reporting
Takeda5 minutes -
Antibody Levels over Time
Takeda2 minutes -
Laboratory diagnostic tests
Takeda -
Differential diagnosis
Takeda1 minutes -
Dengue disease states
Takeda4 minutes -
Burden of Dengue
Takeda38 minutes -
Challenges in the management and diagnosis of Zika, Dengue and Chikungunya
Takeda42 minutes -
Immune response to dengue virus
Takeda4 minutes -
Dengue virus and pathobiology
Takeda1 minutes -
Clinical diagnosis and management of dengue
PAHO -
Dengue Clinical Case Management
CDC -
The global trends and regional differences in incidence of dengue infection from 1990 to 2019: An analysis from the Global Burden of Disease Study 2019
Takeda2 minutes -
NS1 and its potential association with severe dengue
Takeda3 minutes -
Dengue - unanswered scientific questions
Takeda11 minutes -
Antibody-dependent enhancement of severe dengue disease in humans
Takeda2 minutes -
Dengue: diagnosis and treatment updates
ISID62 minutes -
Resources for patient support
Takeda3 minutes -
Causes of fever in returning travelers: A European multicenter prospective cohort study
Takeda2 minutes -
Dengue diagnosis: unique challenges in a time of a pandemic
Medscape15 minutes -
Dengue serotypes
Takeda4 minutes -
Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes
Takeda2 minutes -
A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection
Takeda2 minutes -
Coagulation abnormalities in Dengue fever infection: A systematic review and meta-analysis
Takeda2 minutes -
Distinct Dengue Epidemiology and Viral Characteristics in Indonesia
ADVA25 minutes -
Dengue Virus Life Cycle
HHMI BioInteractive4 minutes -
Zika and dengue but not chikungunya are associated with Guillain–Barré syndrome in Mexico: A case-control study
Takeda2 minutes
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
This website is intended for informational purposes only and is not a substitute for healthcare professional’s clinical knowledge or professional judgment.
© Copyright 2025 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2023